These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8724215)

  • 1. Epidemiology and prevention of breast cancer.
    Kelsey JL; Bernstein L
    Annu Rev Public Health; 1996; 17():47-67. PubMed ID: 8724215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of susceptibility to breast cancer.
    Hulka BS
    Prog Clin Biol Res; 1996; 395():159-74. PubMed ID: 8895988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and screening for breast cancer.
    Harper GR; Englisbe BH
    Cancer Detect Prev; 1993; 17(4-5):551-5. PubMed ID: 8242657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
    Vogel VG
    Menopause; 2008; 15(4 Suppl):782-9. PubMed ID: 18596599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer epidemiology: summary and future directions.
    Kelsey JL
    Epidemiol Rev; 1993; 15(1):256-63. PubMed ID: 8405209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer epidemiology.
    Kelsey JL; Berkowitz GS
    Cancer Res; 1988 Oct; 48(20):5615-23. PubMed ID: 3048646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Kotsopoulos J; Lubinski J; Lynch HT; Klijn J; Ghadirian P; Neuhausen SL; Kim-Sing C; Foulkes WD; Moller P; Isaacs C; Domchek S; Randall S; Offit K; Tung N; Ainsworth P; Gershoni-Baruch R; Eisen A; Daly M; Karlan B; Saal HM; Couch F; Pasini B; Wagner T; Friedman E; Rennert G; Eng C; Weitzel J; Sun P; Narod SA; ; Garber J; Osborne M; Fishman D; McLennan J; McKinnon W; Merajver S; Olsson H; Provencher D; Pasche B; Evans G; Meschino WS; Lemire E; Chudley A; Rayson D; Bellati C
    Breast Cancer Res Treat; 2007 Oct; 105(2):221-8. PubMed ID: 17245541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous estrogens and other factors in the epidemiology of breast cancer.
    Kelsey JL; Fischer DB; Holford TR; LiVoisi VA; Mostow ED; Goldenberg IS; White C
    J Natl Cancer Inst; 1981 Aug; 67(2):327-33. PubMed ID: 6943372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous and exogenous endocrine factors.
    Henderson BE
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):577-98. PubMed ID: 2691490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the epidemiology of human breast cancer.
    Kelsey JL
    Epidemiol Rev; 1979; 1():74-109. PubMed ID: 398270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics relating to ovarian cancer risk: implications for prevention and detection.
    Whittemore AS
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S15-9. PubMed ID: 7835800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of reproductive, familial and socioeconomic risk factors for breast cancer using NHANES I data.
    Carter CL; Jones DY; Schatzkin A; Brinton LA
    Public Health Rep; 1989; 104(1):45-50. PubMed ID: 2493661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
    Fakkert IE; Jansen L; Meijer K; Kok T; Oosterwijk JC; Mourits MJ; de Bock GH
    Breast Cancer Res Treat; 2011 Aug; 129(1):157-64. PubMed ID: 21373873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of familial and hormonal risk factors for breast cancer.
    Brinton LA; Hoover R; Fraumeni JF
    J Natl Cancer Inst; 1982 Oct; 69(4):817-22. PubMed ID: 6956759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology of breast cancer].
    Sancho-Garnier H
    Bull Acad Natl Med; 1998; 182(8):1621-32; discussion 1632-3. PubMed ID: 10188308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.